Recruiting
Sarcoma+4
RecruitingStudy of zanidatamab in adult patients with HER2-positive solid tumors (endometrial, colorectal, head & neck, sarcoma) or HER2-mutant non-small cell lung cancer
InvestigationalNo placebo
Study of zanidatamab in adult patients with HER2-positive solid tumors (endometrial, colorectal, head & neck, sarcoma) or HER2-mutant non-small cell lung cancer
InvestigationalNo placebo
- Disease:SarcomaHead and neck cancer+3
- Substances:Zanidatamab
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Zanidatamab
- Sponsor:Unicancer